US 12097263
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
granted A61KA61K2039/505A61K47/60
Quick answer
US patent 12097263 (Muscle targeting complexes and uses thereof for treating myotonic dystrophy) held by Dyne Therapeutics, Inc. expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Dyne Therapeutics, Inc.
- Grant date
- Tue Sep 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K2039/505, A61K47/60, A61K47/65, A61K47/6807